An oligoarray for the detection of human papillomavirus type 16 variants

International Journal of Gynecological Cancer

Volumn 17, Issue 5, 2007, Pages 1083-1091

  Mendoza Lorenzo, P ^a   Maldonado, R ^b   Pacheco, R ^b   Mendez A ^b   Pina Sanchez P ^a   Rangel, A ^a   Vazquez Ortiz G ^a   Salcedo, M ^a,c  

^a Oncogenomics Laboratory   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

HPV 16; Oligoarray; Variants

Indexed keywords

DNA; OLIGONUCLEOTIDE;

ARTICLE; DNA MICROARRAY; DNA SEQUENCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; GENETIC VARIABILITY; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS DETECTION; VIRUS GENE; VIRUS STRAIN;

DNA MUTATIONAL ANALYSIS; DNA PROBES; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 34548671209     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00832.x     Document Type: Article

References (42)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature 2002 2 : 342 50.
2. Rousseau MC, Straif K, Siemiatycki J. IARC monograph on evaluation of carcinogenic risks of human: human papillomaviruses. Vol. 64. Lyon, France : IARC Scientific Publication, 1995.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001 94 : 153 6.
4. Mexican Ministry of Health. Registro histopatológico de neoplasias malignas, compendio de mortalidad y morbilidad. México: Secretaría de Salud, 1998.
5. Muñoz N, Bosh FX, de San Jose S et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 27.
6. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of human papillomavirus. Virology 2004 324 : 17 27.
7. Piña-Sánchez P, Hernández-Hernández P, López-Romero R et al. Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. Int J Gynecol Cancer 2006 16 : 1 7.
8. Torroella-Kouri M, Morsberger S, Carrillo A et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998 70 : 115 20.
9. Hildesheim A, Schiffman M, Bromley C et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001 93 : 315 7.
10. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005 32S : S1 6.
11. Bosh FX. Epidemiology of human papillomavirus infections: new options for cervical cancer preventions. Salud Publica Mex 2003 45 : S326 39.
12. Schiffman P, Castle P. Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003 95 : E2.
13. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003 16 : 1 17.
14. Lorincz AT. Screening for cervical cancer: new alternatives and research. Salud Publica Mex 2003 45 : S376 87.
15. Yamada T, Wheeler CM, Halpern AL, Stewart AM, Hildesheim A, Jenison S. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 1995 69 : 7743 53.
16. Yamada T, Manos MM, Peto J et al. Human papillomavirus type 16 sequence variation in cervical cancer: a worldwide perspective. J Virol 1997 71 : 2463 72.
17. Wheeler C, Yamada T, Hildesheim A, Jenison E. Human papillomavirus type 16 sequence variations: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 1997 35 : 11 9.
18. Villa LL, Sichero L, Rahal P et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000 81 : 2959 68.
19. Giannoudis A, Herrington C. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001 193 : 295 302.
20. Berumen J, Ordoñez RM, Lazcano E et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001 93 : 1325 30.
21. Gonzales-Loza M del R, Miery Teran J, Puerto-Solís M, García-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J Clin Virol 2004 29 : 95 8.
22. Peyton CL, Schiffman M, Lorincz AT et al. Comparison of PCR and hybrid capture based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998 36 : 3248 54.
23. Hubbard R. Human papillomavirus testing methods. Arch Pathol Lab Med 2003 127 : 940 5.
24. Maldonado-Rodriguez R, Espinosa-Lara M, Calixto-Suaréz A, Beattie W, Beattie K. Hybridization of glass-tethered oligonucleotide probes to target strands preannealed with labeled auxiliary oligonucleotides. Mol Biotechnol 1999 11 : 1 12.
25. Maldonado-Rodriguez R, Espinosa-Lara M, Barrera-Leon O et al. Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization. Mol Biotechnol 2003 25 : 113 29.
26. Rangel-López A, Maldonado-Rodríguez R, Salcedo-Vargas M, Espinosa-Lara JM, Méndez-Tenorio A, Beattie K. Low density DNA microarray for detection of most frequent TP53 missense point mutations. BMC Biotechnol 2005 5 : 8.
27. Méndez-Tenorio A, Beattie KL, Doktycz MJ, Maldonado- Rodríguez M, Reyes-López A. Genosensor Probe Designer and virtual hybridization. Software para el diseño de sondas para genosensores de DNA. In press.
28. Terris M, Peehl D. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent of the primer set utilized. Urology 1997 50 : 150 6.
29. Bohm S, Wilczynsky SP, Pfister H, Iftner T. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int J Cancer 1993 55 : 791 8.
30. Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 1999 80 : 1725 33.
31. Chan SY, Ho L, Ong CK et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992 66 : 2057 66.
32. Kim CJ, Jeong JK, Park M et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol 2003 89 : 210 7.
33. Liu CH, Ma WL, Shi R, Ou YO, Zhang B, Zheng WL. Possibility of using DNA chip technology for diagnosis of human papillomavirus. J Biochem Mol Biol 2003 36 : 349 53.
34. Delrio-Lafreniere SA, Browning MK, McGlennen RC. Low-density addressable array for the detection and typing of the human papillomavirus. Diagn Microbiol Infect Dis 2004 48 : 23 31.
35. Klaassen CHW, Prinsen CFM, de Valk HA, Horrevorts AM, Jeunink MAF, Thunnissen FB. DNA microarray format for detection and subtyping of human papillomavirus. J Clin Microbiol 2004 42 : 2152 60.
36. Oh TJ, Kim CJ, Woo SK et al. Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses. J Clin Microbiol 2004 42 : 3272 80.
37. ™: a model system for detection of multiple pathogens. BMC Infect Dis 2003 3 : 1 9.
38. Xi LF, La Koutskya A, Galloway DA et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997 89 : 796 802.
39. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 1996 70 : 6987 93.
40. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive carcinoma than the prototype. Cancer Res 1998 58 : 829 33.
41. Andersson S, Alemi M, Rylander E et al. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic. Br J Cancer 2000 83 : 307 10.
42. Brady C, Duggan-Keen M, Davidson J, Varley J, Stern P. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J Gen Virol 1999 80 : 3233 40.